Table 1 characteristics of the studies for the relationship between VEGF levels (pg/ml) and SLE risk
Author, year | Country | Sex (F/M) | Age (Years) | SLE | Control | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
SLE | Control | SLE | Control | Mean | SD | N | Mean | SD | N | ||
Navarro 2002 | Mexico | 24/4 | 19/5 | 36.6 ± 16.1 | 29.2 ± 8.5 | 70.25 | 168.26 | 28 | 23.48 | 153.7 | 24 |
Heshmat 2007 | Egypt | 24/1 | 29/1 | 14.1 ± 2.6 | 14 ± 2.5 | 579.5 | 184.7 | 25 | 113.2 | 30.8 | 30 |
Kuryliszyn-Moskal 2007 | Poland | 44/3 | NC | 40.8 ± 13.6 | NC | 225 | 187.5 | 44 | 150 | 140 | 30 |
Tanaseanu 2007 | Romania | 12/3 | NC | 35 ± 15 | NC | 744.2 | 425.1 | 15 | 330.3 | 84.16 | 10 |
Ciprandi 2008 | Italy | 40/0 | 33/7 | 41.95 ± 8.3 | 43 ± 8.2 | 662.5 | 700 | 40 | 500 | 512.5 | 40 |
Colombo 2009 | Italy | 80/0 | 80/0 | 42.6 ± 9.1 | 40.1 ± 9.5 | 307.9 | 292.2 | 80 | 120.7 | 118.4 | 80 |
Kuryliszyn-Moskal 2009 | Poland | 76/4 | NC | 39.5 ± 13.3 | NC | 355.9 | 292.2 | 47 | 144.6 | 54.4 | 33 |
Edelbauer 2012 | Austria | 17/6 | 5/15 | 15 ± 5 | 12 ± 3 | 216 | 28 | 14 | 40 | 9 | 20 |
Robak 2013 | Poland | 55/5 | 17/3 | 39.2 ± 27.5 | NC | 431.9 | 311.6 | 60 | 202.5 | 117.6 | 20 |
Willis 2014 | USA | 18/3 | 27/5 | 44.6 ± 25.5 | NC | 453.99 | 261.19 | 21 | 113.58 | 88.29 | 32 |
Zhou 2014 | China | 50/4 | 22/6 | 36.81 ± 12.52 | 37.82 ± 12.86 | 91.47 | 108.67 | 54 | 47.29 | 52.62 | 28 |
Bărbulescu 2015 | Romania | 16/2 | 16/1 | 45 ± 10.81 | NC | 68.99 | 71.06 | 18 | 31.84 | 11.74 | 17 |
Liu 2015 | China | 59/16 | 31/9 | 35.42 ± 11.79 | 33.62 ± 10.21 | 327.5 | 702.55 | 75 | 172.9 | 207.45 | 40 |
Ghazali 2017 | Malaysia | 44/2 | 26/0 | 32.39 ± 11.46 | 33.19 ± 10.30 | 553.65 | 398.64 | 46 | 343 | 198.21 | 26 |
Merayo-Chalico 2018 | Mexico | NC | NC | 34.6 ± 4.2 | 36 ± 4.1 | 653 | 275 | 6 | 223 | 116 | 6 |